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Phytochemical and biological activity studies of the Bhutanese medicinal plant
corydalis crispa
Abstract
The chemical constituents and biological activities of Corydalis crispa (Fumariaceae) were investigated
for the first time. The phytochemical study resulted in the isolation of nine known isoquinoline alkaloids:
protopine (1), 13-oxoprotopine (2), 13-oxocryptopine (3), stylopine (4), coreximine (5), rheagenine (6),
ochrobirine (7), sibiricine (8) and bicuculline (9), with complete NMR data for 2 and 3 provided here for the
first time. Crude extracts exhibitedsignificant anti-inflammatory (p < 0.01) activity against TNF-alpha
production in LPS activated THP-1 cells. The acetylcholinesterase inhibitory activity of compounds 2, 4
and 7 and the antiplasmodial activity of compound 5 against P. falciparum strains TM4/8.2 and K1CB1
(multidrug resistant strain) are reported here for the first time. Stylopine (4) did not show antimalarial
activity against the K1CB1 strain in contrast to a previous report. This study generated a scientific basis
for the use of this plant in Bhutanese traditional medicine, either individually or in combination with other
medicinal ingredients to treat a broad range of disorders. This study also identified compound 5 as
potential new antimalarial lead compound.
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The chemical constituents and biological activities of Corydalis crispa (Fumariaceae) were investigated for the first time. The phytochemical study resulted in
the isolation of nine known isoquinoline alkaloids: protopine (1), 13-oxoprotopine (2), 13-oxocryptopine (3), stylopine (4), coreximine (5), rheagenine (6),
ochrobirine (7), sibiricine (8) and bicuculline (9), with complete NMR data for 2 and 3 provided here for the first time. Crude extracts exhibited significant
anti-inflammatory (p<0.01) activity against TNF-α production in LPS activated THP-1 cells. The acetylcholinesterase inhibitory activity of compounds 2, 4
and 7 and the antiplasmodial activity of compound 5 against P. falciparum strains TM4/8.2 and K1CB1 (multidrug resistant strain) are reported here for the
first time. Stylopine (4) did not show antimalarial activity against the K1CB1 strain in contrast to a previous report. This study generated a scientific basis for
the use of this plant in Bhutanese traditional medicine, either individually or in combination with other medicinal ingredients to treat a broad range of
disorders. This study also identified compound 5 as potential new antimalarial lead compound.
Keywords: Corydalis crispa, isoquinoline alkaloid, Bhutanese traditional medicine, anti-inflammatory, antiplasmodial, anti-acetylcholinesterase.

The genus Corydalis (Fumariaceae) are a rich source of
isoquinoline alkaloids which mediate chemical defence against a
variety of micro-organisms and herbivores [1-2]. While few plant
species of this genus were reported for cattle and sheep poisoning
[1], many species are regarded as non-toxic and are being used in
Asian folklore medicines for treating different types of ailments [34]. Owing to these interesting inherent properties, the Corydalis
genus has been extensively studied. More than 58 Corydalis species
have been studied phytochemically with over 190 isoquinoline
alkaloids reported [5].
However, no phytochemical and biological activity studies on the
Bhutanese medicinal plant, C. crispa have been reported. Locally, it
is known as ngo-ba-sha-ka in Bhutan and contributes to the
preparation of as many as 21 important multi-ingredient Essential
Traditional Medicine Drugs (ETMDs) or polyherbal formulations
[6]. As an individual plant, C. crispa is used in the Bhutanese
traditional medicine (BTM) as a febrifuge and for treating
infections in the blood, liver and bile which correlate to the signs
and symptoms of parasitic and microbial infections, tumor and
inflammatory conditions [7]. We previously reported the
antiplasmodial, antimicrobial, anti-Trypanosoma brucei rhodesiense
and cytotoxicity activities of the crude extracts of this plant [7]. In
this study, since this plant is also ethnopharmacologically indicated
for the management of various inflammatory conditions in Bhutan,
we first assessed the anti-inflammatory potential of its crude
extracts and then investigated the phytochemical components of this
plant followed by bioassays on the major compounds with a view to
derive potential new drug lead compounds and generate scientific
evidence for its ethnopharmacological uses.

Figure 1: The structures of compounds 1-9.

The phytochemical study of this plant resulted in the isolation of
nine known isoquinoline alkaloids (Figure 1): protopine (1), 13oxoprotopine (2), 13-oxocryptopine (3), stylopine (4), coreximine
(5), rheagenine (6), ochrobirine (7), sibiricine (8) and bicuculline
(9).
Compounds 1-4 belonged to the class of protopine alkaloids;
compound 5 to the class of protoberberine alkaloids; compound 6 to
the class of rhoeadine alkaloids; compounds 7 and 8 to the class of
spirobenzylisoquinoline alkaloids; and compound 9 to the class of
phthalide-isoquinoline alkaloids. The presence of more than one
class of these alkaloids from a genus or even within a species has
been reported [8]. Compound 6 has been reported previously from
the genus of Papaver, Meconopsis, Glaucum, Roemeria, Bocconia
and Fumaria [9-10]. However, this is the first rhoeadine-type
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alkaloid being isolated from the genus Corydalis (Fumariaceae). Its
presence in C. crispa is not that surprising since: a) rhoeadine
alkaloids have been reported from its close relative Fumaria
parviflora belonging to the same family of Fumariaceae; and b)
rhoeadine alkaloids are the biogenetic derivatives of protopine [10].
Furthermore, direct evidence for the incorporation of labeled
protopine into rhoeadine in P. rhoeas has been documented [11].
The literature on compounds 2 and 3, lacked full NMR
characterisation and we have presented here for the first time (Table
1).
13-Oxoprotopine (2) was previously characterized only by melting
point, UV, IR and MS data [12]. Compound 2 was isolated here as a
white amorphous solid. Its melting point, molecular formula and the
major ion fragmentation pattern corresponded with the reported data
for 13-oxoprotopine [12-13]. The 1H-NMR spectrum of 2 showed
the aromatic (CH) protons resonating at δ 7.43 (1H, s), 6.69 (1H, s),
6.83 (1H, d, J = 8 Hz), and 7.46 (1H, br s). The gHSQC showed
these protons linked to the carbon signals resonating at δ 109.1 (C1), 109.6 (C-4), 107.4 (C-11) and 125.9 (C-12), respectively.
13
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Table 1: C-NMR (125 MHz) and H (500 MHz) data of Compounds 2 and
3.
Position

δC

1
2
3
4
4a
5
6
8
8a
9
10
11
12
12a
13, C=O
14, C=O
14a
N-CH3
2-OCH3
3-OCH3
2,3-OCH2O
9,10-OCH2O

109.1
145.1
148.6
109.6
131.9*
29.14
46.12*
50.06
120.0*
146.0*
147.0*
107.4
125.9
128.0*
182.1*
191.7
131.5
42.36
–
–
101.3
101.9

*

2 (in CDCl3)
δ H (mult., J (Hz)
7.43 s
6.69 s
1.26 br s
2.65 br s
3.64 br s

6.83 d (8)
7.46 br s

1.92 s
5.99 s
6.05 s

3 (in CDCl3)
δC
111.8
147.0
150.6
112.4
130.7
29.2
46.0*
50.1
120.0
145.2
149.9
107.4
125.9
128.1
182.0 *
191.9
131.0*
42.1
56.0
55.9
–
101.9

δ H (mult., J (Hz)
7.48 s
6.70 s
1.64 br s
2.64 br s
3.67 br s

6.83 d (8)
7.49 br s

1.86 s
3.89 s
3.94 s
–
6.04 s

Signal only observed in the gHMBC spectrum.

The two methylenedioxy protons were observed at δ 5.99 (2H, s)
and 6.05 (2H, s) with its connected carbons resonating at δ 101.3
and 101.9, respectively. The methylene (3×CH2) protons attached to
C-atoms of C-5, C-6 and C-8 resonated as very broad peaks in the
region of δ 1.26-3.64. The N-methyl protons resonated at δ 1.92
(3H, s). The C-13 and C-14 carbonyl groups resonated at δ 182.1
and δ 191.7, respectively. The gHMBC defined the final structure 2.
To further confirm the structure 2, it was synthesized by oxidation
of compound 1 with mercuric acetate and the compound
synthesized was found identical to 13-oxoprotopine (2) by TLC,
MS and 1H-NMR analysis.
13-Oxocryptopine (3) was reported only from the family
papaveraceae (P. somniferum) [9, 12] and this is the first report
from the genus Corydalis (Fumariaceae). It was previously
identified based on its melting point, MS and 1H-NMR data [12,14]
and its 13C-NMR data has been lacking. Here, this compound 3 was
obtained as an optically inactive pale green solid. The molecular
formula, ion fragmentation pattern and the 1H-NMR data were
consistent with those reported for 13-oxocryptopine (3) [12, 14].
The APT spectra indicated the presence of three methyl groups,

four methylene, four methine and ten quaternary carbons. From the
gHSQC spectrum the four aromatic protons (CH) correlated to C-1,
C-4, C-11 and C-12 carbons whose signals resonated at δ 111.8,
112.4, 107.4, and 125.9, respectively. A signal at δ 42.1 was
assigned to the N-methyl carbon and the signals at δ 55.9 and 56.0
were assigned to the two methoxy carbons. The carbon of the
methylenedioxy group resonated at δ 101.9. The long range
gHMBC correlation established the structure 3.
The other known compounds were identified through MS library
matching techniques (NIST08s) and then confirmed through
comparison of their melting point, optical rotation, mass and NMR
spectra with those reported in the relevant literature. Compound 1
(950 mg) was identified as protopine [15-17], compound 4 (5 mg)
as stylopine [15, 18-20], compound 5 (1 mg) as coreximine [21],
compound 6 (1 mg) as rheagenine [10], compound 7 (60.6 mg) as
ochrobirine [22-25], compound 8 (0.8 mg) as sibiricine [8, 23] and
compound 9 as bicuculline [26-27].
In this study, prior to the investigation of its phytochemical contents
and the biological activities of the major alkaloids, we first assessed
the anti-inflammatory potential of its crude extracts against proinflammatory cytokine, tumor necrosis factor-α (TNF-α) in LPS
activated THP-1 cells. The uncontrolled production of this proinflammatory cytokine by the immune system in response to
infection, stimulates the over production of reactive oxygen species
(ROS) which have been implicated in the pathogenesis of many
forms of disease [28]. Thus, the pro-inflammatory cytokine (TNFα) in LPS activated THP-1 cells are commonly used for evaluating
the anti-inflammatory effects of various materials.
The anti-inflammatory assay (Table 2) demonstrated the level of
TNF-α secretion of THP-1 monocytic cells and the percentage of
TNF-α inhibition when incubated with crude extracts and pure
alkaloids of the plant in the presence of LPS. The cytotoxic effects
of the crude extracts and pure alkaloids on THP-1 cells were
determined first on test samples at different concentrations. This
cell viability test compositely indicated that, at 50 µg/mL of crude
extracts and 3.9 µg/mL of pure alkaloids, there were no significant
cell reduction. The percentage of viable cells in each sample was
>90%. The percentage cell viability of RPMI was 97%, DMSO was
98% and dexamethasone was 97%. This suggested that the
inhibition of TNF-α production by the test samples were not
associated with their cytotoxic effects to the THP-1 cells. The THP1 cells in RPMI and THP-1 cells incubated with the crude plant
extracts or pure alkaloids alone (without LPS) did not activate TNFα production at the above mentioned non-cytotoxic concentrations.
In the presence of each of the plant extracts and individual
alkaloids, the TNF-α production was either suppressed or stimulated
in varying degrees as compared to the secretion levels of TNF-α
production of RPMI culture media control and the DMSO solvent
control (Table 2).
Among the four different solvent extracts, the hexane and
dichloromethane extract showed significant anti-inflammatory
activity with the suppression of TNF-α production to the values of
142 pg/ml (77% inhibition) and 71 pg/ml (89% inhibition),
respectively (Figure 2). The suppression of TNF-α production of
these two crude extracts were much higher than the DMSO control
and the positive control drug dexamethasone (Table 2). The
chloroform extract also showed suppression of TNF-α production to
the value of 284 pg/mL (54% inhibition). A Student’s t-test with
one-tailed distribution showed that the results from the hexane and
dichloromethane extracts (p<0.01) and the chloroform extract
(p<0.05) were statistically significant (Figure 2). These significant
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activities suggested that these crude extracts possess compounds
with promising anti-inflammatory properties.
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Figure 2: Anti-inflammatory effects of crude extracts on TNF-α production in
LPS-activated THP-1 monocytic cells. RPMI as cell culture media control;
DMSO as solvent control; Dexamethasone as positive control drug; asterisks
denote statistical significance in relative to solvent control; *(p<0.05);
**(p<0.01); error bars indicate standard deviations.

Guided by the potent biological activities of its crude extracts, out
of nine isolated compounds, we investigated six major compounds
1, 2, 4, 5, 7 and 9 for their anti-inflammatory, antiplasmodial,
antimicrobial, anti-acetylcholinesterase, anti-Trypanosoma brucei
rhodesiense and cytotoxicity activities (Table 2 and Table 3).
Compound 1 exhibited significant anti-inflammatory, antiacetylcholinesterase and the antiplasmodial activities against
Plasmodium falciparum strains: TM4/8.2 (a wild type chloroquine
and antifolate sensitive strain) and K1CB1 (multidrug resistant
strain) (Table 2). It also showed broad range of mild level
antimicrobial activity against different bacterial strains as compared

to other test compounds (Table 3). The antiplasmodial,
antimicrobial, and anti-inflammatory activities of this compound
were found in line with the previously reported data [15, 29-32].
Compounds 2 and 4 displayed stimulated effects on TNF-α
production and moderately inhibited acetylcholinesterase. Kaya et
al. [33] reported that compound 4 (stylopine) had significant
antimalarial activity against the drug resistant P. falciparum K1
strain with IC50 values of 0.23 μg/mL. However, we found that
compound 4 was inactive even at the highest concentration of 4–4.6
μg/mL. Indeed, previous studies indicated that compound 4 was
inactive against P. berghei and P. falciparum [15, 34-35].
Compound 5 showed significant antiplasmodial activity against
TM4/8.2 and K1CB1 strains with IC50 values of 5.56 ± 0.63 μg/mL
and 6.87 ± 1.09 μg/mL, respectively. Thus, it has the potential to be
a new candidate for antimalarial drug lead. This compound also
moderately inhibited acetylcholinesterase (Table 2) and inhibited
Helicobacter pylori and Bacillus subtilis with the MIZ of 6 and 5
mm, respectively (Table 3). This MIZ values were significant when
compared to that of the positive control, amoxicillin which inhibited
the same strain with a MIZ value of 7 and 10 mm. However, they
both showed only weak MIC values of 125 µg/mL. In fact, all the
alkaloids tested here showed weak antibacterial activity against H.
pylori with MIC values of 125 µg/mL. Compound 7 showed weak
anti-inflammatory and moderate anti-acetylcholinesterase activities.
The anti-inflammatory, antimicrobial, antiplasmodial, antiTrypanosoma brucei rhodesiense and the cytotoxicity activities of
the crude extracts were very interesting for the fact that this plant is
being used in the Bhutanese traditional medicine (BTM) as a
febrifuge and for treating infections in the blood, liver and bile
which correlate to the signs and symptoms of parasitic and
microbial infections, tumor and inflammatory conditions [7].

Table 2: Bioactivities of the crude extracts and the pure compounds 1, 2, 4, 5, 7, and 9 isolated from C. crispa.
Samples
MeOH extract
Hexane extract
CH2Cl2 extract
CHCl3 extract
1
2
4
5
7
9
RPMI
DMSO
Dexamethasonec
Galanthamined
Chloroquinee
Cycloguanile
Pyrimethaminee
PB113f
Ellipticineg
Doxorubicing

Anti-inflammatory
TNF-α
Activity
(pg/mL)
(%)

AChEa
MIR
(nmol)

Antiplasmodial (P. falciparum)
TM4/8.2
K1CB1
IC50 ( μg/mL)
IC50 ( μg/mL)

Anti-Tbrb
IC50
( μg/mL)

778 ±3
142 ±17
71 ±17
284 ±10
467 ±4
862 ±14
679 ±28
632 ±4
606 ±30
791 ±11
502±43
620±54
258 ±65

Nt
Nt
Nt
Nt
0.14
1.31
0.15
0.53
0.14
>2.72

11.53 ±4.83
14.57 ±1.76
12.09 ±0.58
2.11 ±0.55
1.45±0.53
>4.6
>4.0
5.56±0.63
>9.2
>9.2

13.24 ±0.59
15.82 ±3.94
11.27 ±3.14
1.89 ±0.20
1.38±0.31
>4.6
>4.0.
6.87±1.09
>9.2
>9.2

>10
>10
>25
4.63 ±0.53
>3.5
>3.7
>3.2
>8.2
>9.2
>9.2

0.0096
0.0095
0.0200

0.089± 0.01
0.81 ± 0.19
7.7 ± 2.14

+ (25)
− (77)
− (89)
− (54)
− (25)
+ (39)
+ (10)
+ (1)
− (2)
+ (28)

Cytotoxicity
Vero cells
KB cells
IC50 ( μg/mL)
IC50 ( μg/mL)
>25
>25
>25
>25
>3.5
>3.7
>3.2
>8.2
>9.2
>9.2

>25
>25
>25
12.50
>3.5
>3.7
>3.2
>8.2
>9.2
>9.2

0.003

0.064
0.093
0.56

a

Acetylcholinesterase inhibitory activity. b Anti-Trypanosoma brucei rhodesiense activity. Nt: Not tested; +: activated; −: inhibited.
Reference drug for anti-inflammatory activity.d Reference drug for acetylcholinesterase activity. e Reference drugs for antiplasmodial activity.
f
Positive control for anti-Trypanosoma brucei rhodesiense activity. g Positive controls for cytotoxicity activity.
c

Table 3: Antimicrobial activities of the crude extracts and the pure compounds of C. crispa (Minimum Inhibition Zone (MIZ) in mm, well diameter = 4 mm;
Minimum Inhibitory Concentration (MIC) in µg/mL).
Bacterial and fungal strains
Samples

V. cholerae
MIZ

MIC

S. aureus
MIZ

MIC

MRSA
MIZ

MIC

E. coli
MIZ

MIC

B. subtilis

S. epidermidis

MIZ

MIZ

MIC

MIC

H. pylori
MIZ

MIC

C. albicans
MIZ

MIC

4

a

MeOH extract
Hexane extract
CH2Cl2 extract
CHCl3 extract
1
2
4
5
7
9
Amoxicillina
Vancomycina
Amphotericin Bb

5.5
6
5
7
7.5
Nt
Nt
Nt
Nt
Nt
6

1250
2500
1250
625
250
Nt
Nt
Nt
Nt
Nt
7.8

−
6
6
7
8
4.5
5.5
5.5
4.5
6
31

−
2500
2500
1250
250
500
250
250
500
500
<1

−
6
5.5
7
5.5
4.5
5
4.5
4.5
4.5

−
2500
1250
1250
250
500
500
250
250
250

15

4

6
5.5
6
7
7
6
6
6
5
5
9

1250
1250
1250
1250
250
250
250
250
250
250
8

−
−
5.8
7
−
5
5
5
5
5
10

−
−
625
625
−
250
250
125
250
250
63

5
6
6
7
−
Nt
Nt
Nt
Nt
Nt
20

1250
2500
1250
625
−
Nt
Nt
Nt
Nt
Nt
16

5.3
6.5
6.3
6.5
5.3
5
5
6
5
5
7

Standard drug as a positive control for antibacterial testing.b Standard drug as a positive control for antifungal testing.
Nt: Not tested, −: Not active.

Thus, our study verified an ethnopharmacological uses of C. crispa
and strongly suggested that this plant can be a source of broad
spectrum, biologically active natural products. Unlike the crude
chloroform extract of this plant, none of the six pure alkaloids tested
here exhibited anti-Trypanosoma brucei rhodesiense and
cytotoxicity activities. The anti-acetylcholinesterase activity of
compounds 2, 4 and 7, and the antiplasmodial activity of compound
5 are reported here for the first time. Since compounds 1 and 5
exhibited significant antiplasmodial, moderate acetylcholinesterase
inhibition and mild level antimicrobial activities, it may be deduced
that these two alkaloids (in alone or synergistically) may be
responsible for the major activity of this plant. It is also possible
that other minor alkaloids which were isolated here (but not tested)
and the non-alkaloid components which we could not readily isolate
may be responsible for the broad range of interesting biological
activities of the crude extract of a plant.
In summary, our study found the following: a) protopine (1) (950
mg/2 kg dry weight) was the major alkaloid of C. crispa, b)
complete NMR data for compounds 2 and 3 were lacking which we
furnished here for the first time, c) compound 5 showed significant
in vitro antiplasmodial activity without cytotoxicity and was
identified as a potential scaffold that could generate more leads with
enhanced antiplasmodial activity, and d) the in vitro biological
activities were in alignment with the ethnopharmacological uses of
this plant and thus substantiate its use in BTM, either individually
or in combination with other medicinal ingredients, to treat a broad
range of disorders.
Experimental
General: A rotary evaporator was used for solvent evaporation
under reduced pressure at 35 °C-50 °C. Flash column
chromatography packed with Merck Kieselgel 60 PF254 was used
for separation and purification of alkaloids. Aluminium-backed
silica plates (0.2 mm silica thickness, Merck) were used for
separating isolates of smaller quantities. UV light (short wavelength
of 254 nm, long wavelength of 366 nm) and Dragendorff’s reagent
were used for visualization and detection of the separated alkaloidrich bands on TLC plates. Micromass Waters Platform LCZ (single
quadrupole, MeOH as solvent) was used for obtaining the LR-ESIMS. Shimadzu GCMS-QP-5050 was used for recording the LR-EIMS by the direct insertion technique (at 70 eV). Micromass Waters
Q-ToF Ultima (quadrupole time-of-flight) mass spectrometer was
used for acquiring HR-ESI-MS. A 500 MHz Varian Unity Inova,
500 MHz Varian Premium Shield (VNMRS PS 54), and 300 MHz
Varian Mercury spectrometer were used for obtaining the NMR
spectra (1H-NMR, gCOSY, 13C-NMR, APT, gHMBC, gHSQC, and
gNOESY) using deuterated solvents (CD3OD or CDCl3) depending
upon the solubility of compounds. IR spectra were obtained using a
Smart Omni-Sampler Avator ESP Nicolet spectrometer. Reichert
hot-stage apparatus was used for determining the melting point of
the compounds. A JASCO 2000 Series polarimeter was used for

500
500
500
500
125
125
125
125
125
125
16

−
−
−
5.5
Nt
Nt
Nt
Nt
Nt
Nt

−
−
−
313
Nt
Nt
Nt
Nt
Nt
Nt

18

<1

measuring the optical rotations of the compounds using a sodium
lamp and averages of ten optical readings were taken to obtain the
observed rotation value.
Plant material: C. crispa Prain, is a perennial yellow flowering herb
that grows to about 10-23 cm tall arising from stout woody
rootstock [36-37]. The whole part of wild C. crispa was collected
from Thuphu (Altitude: 3962 m; Latitude: 27° 51' 15.4''; Longitude:
89° 27' 12.8''; global positioning system (GPS) point number: 187;
Site number: P187; Slope: 40°; Aspect: South-East), under Lingshi
block in Bhutan in August 2009. The collected plant material was
air-dried and a herbarium specimen with voucher number 78 was
deposited at the herbarium of the PRU, Thimphu, Bhutan.
Extraction and isolation: The air-dried plant material (2 kg) was
chopped into small pieces and was repeatedly extracted with
methanol (AR/HPLC grade, 5 × 3 L over 48 h). The extract was
filtered and then concentrated using a rotary evaporator to afford the
crude methanol extract (58.22 g). The MeOH extract (10 g) was
acidified with 5% HCl and then subjected to sequential
fractionation and extraction using hexane (5 × 60 mL) and CH2Cl2
(5 × 60 mL). Two fractionated extracts were concentrated resulting
into hexane extract (1.34 g) and the CH2Cl2 extract (2.90 g). The
remaining acidified aqueous solution was basified (pH 9-11) with
NH4OH solution, then extracted with CHCl3 (5  60 mL). The
CHCl3 extract was washed (H2O), dried (Na2SO4) and the solvent
was evaporated under reduced pressure to yield a crude alkaloidrich CHCl3 extract (80 mg). Dragendorff’s reagent was prepared
[38] for staining the TLC plate loaded with alkaloid. A small
portion of each of these crude extracts (40 mg each) was used for
biological activity studies. Each extract obtained above was then
subjected to fractional crystallization (mostly methanol/chloroform)
followed by repeated separation and purification processes using
column chromatography on silica gel (mobile phase: gradient eluant
of increasing solvent polarities mainly using MeOH (1-30%) and
CHCl3) until pure alkaloids were obtained. Fractions of smaller
quantities and those compounds with closer Rf values were
separated
repeatedly
using
Preparative
Thin
Layer
Chromatography. Finally, nine known isoquinoline alkaloids 1–9
(Figure 1) were isolated.

13-Oxoprotopine (2)
17.6 mg (0.00088 % dry weight), white amorphous solid.
MP: 226-228 °C.
[α]D: inactive.
1
H-NMR and 13C-NMR: see Table 1.
LR-ESI-MS (m/z): 368 [M+H+].
LR-EI-MS (m/z): 367 [M+•], 295, 279, 257, 237, 209, 190, 162
(100%), 149, and 134.
HR-ESI-MS (m/z): 368.1159 [M+H+] (354.1129 calc. for
C20H18NO6+).
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13-Oxocryptopine (3)
4.5 mg (0.000225% dry weight), pale green solid.
MP: 180-183 °C.
[α]D: inactive.
IR (KBr): νmax 792, 939, 1042, 1239, 1365, 1454, 1484, 1656 cm-1.
1
H-NMR and 13C-NMR see Table 1.
LR-ESI-MS (m/z): 384 [M+H+].
LR-EI-MS (m/z): 383 [M+•], 340, 312, 297, 277, 253, 220, 204, 190,
162 (100%), 149 and 134.
HR-ESI-MS (m/z): 384.1461 [M+H+] (384.1442 calc. for
C21H22NO6+).
Anti-inflammatory assay: The methanol, hexane, dichloromethane
and chloroform extracts of C. crispa were prepared using the
method described by Wangchuk et al., [7]. Cell culture and in vitro
bioassays were performed as previously described [39]. Cells were
incubated with crude plant extracts and pure compounds of C.
crispa alone or in combination with purified LPS (100 ng/mL) from
Escherichia coli serotype O127 : B8 (Sigma, USA) for 3.5 hr.
Supernatants were collected from individual wells by centrifugation
and assayed for TNF. The cell viability or the cytotoxic effects of
crude extracts and pure compounds in THP-1 cells were determined
by the Trypan-blue (Gibco-Invitrogen, USA) stain exclusion assay.
Cells were incubated with varying concentration of crude extracts
as 0, 25, 50, 100 and 200 µg/mL and that of pure compounds as 0,
1.95, 3.9, 7.8, 15.6 and 31.25 µg/mL. The concentration that
showed the highest cell viability (without significant cell reduction)
was chosen as the final concentration for crude extracts (50 µg/mL)
and pure compounds (3.9 µg/mL). Cell suspension was mixed with
Trypan Blue which stained dead cells. The viable and dead cells
were counted with a hemacytometer under an inverted microscope.
Cell viability was determined from the ratio of viable cells over
total cells. Results were expressed as means with standard
deviations (± SD). The percentage of cell viability was calculated
by the formula:
% Cell viability = 100 × (1−(dead cells/total cells).

TNF-α production in THP-1 cell culture supernatants were
measured using cytokine-specific sandwich quantitative enzymelinked immunosorbent assays (ELISAs) according to the
manufacturer’s instructions (R & D Systems, USA). The 96-well
microtiter plates (Corning, USA) were coated overnight with mouse
anti-human TNF-α antibody as capture antibodies. The plates were
washed with PBST (0.05% Tween 20) to remove excess capture
antibody. To reduce non-specific binding, wells were blocked for 2
h with bovine serum album (BSA) (1% (w/v) of BSA; Sigma,
USA)) and washed with PBST. Recombinant human TNF-α was

used as standard at the concentration of 15.6, 31.5, 62.5, 125, 250,
500, and 1000 pg/mL. The standard or samples were added to
appropriate wells and plates were incubated overnight. After
washing, biotinylated goat anti-human TNF-α antibodies were
added as detection antibodies and the mixture was incubated for 2 h.
The plates were washed with PBST and incubated for 20 min with
streptavidin-horseradish
peroxidase
conjugate.
The
tetramethylbenzidine (TMB) substrate was added to the plates as a
color indicator and was incubated for 20 min. H2SO4 was added to
stop the reaction. Absorbance was measured at 450 nm using a
BioTek® Synergy™ HT (Multi-Detection Microplate Reader, USA).
Cytokine concentration in each well was quantified from a standard
curve and expressed as pg/mL of culture medium.
The commercial anti-inflammatory drug, dexamethasone (10
µg/mL), (Atlantic LabsComp. Ltd., Thailand) was used as a positive
control. The experiments were performed three times in triplicate
(3×3). Results were expressed as means with standard deviations (±
SD). The percentage of TNF-α inhibition was calculated by the
formula:
% TNF-α inhibition = 100 × ((observed/baseline) − 1).
Where observed = secreted TNF-α of experiment (pg/mL) and baseline =
secreted TNF-α of DMSO (pg/mL).

Statistical significance or differences were evaluated by GraphPad
Prism version 5.01 using Student’s t-test with one-tailed
distribution. A p-value ≤ 0.05 was considered statistically
significant.
Acetylcolinesterase inhibitory assay method: A rapid TLC
bioautographic method described by Marston et al. [40] was used
for acetylcholinesterase inhibitory testing. Galanthamine, which is a
frontline AChE inhibitor used to treat Alzheimer’s disease, was
used here as a reference compound. The tests were performed in
triplicate.
Other bioassay methods: The antimicrobial, antiplasmodial, antiTrypanosoma brucei rhodesiense and cytotoxicity assays were
carried out using the methods, test strains and references/standard
drugs as described by Wangchuk et al. [7].
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